Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily that functions as critical regulators of lipid and energy homeostasis. Although intensively studied in mammals, their basic biological functions are still poorly understood. The objective of this work was to characterize PPARb subtypes in a fish, the Atlantic salmon (Salmo salar), in order to address PPAR function and the regulation of lipid homeostasis in lower vertebrates. The screening of an Atlantic salmon genomic library revealed the presence of four genes for PPARb subtypes. Based on comparisons of exons and exon-flanking regions, these genes were assigned into two families, ssPPARb1 and ssPPARb2, each family containing two isotypes: ssPPARb1A and b1B and ssPPARb2A and b2B. Two full-length cDNAs for ssPPARb1A and ssPPPARb2A were isolated. Transcripts for ssPPARb1A and ssPPARb2A have distinct tissue expression profiles, with ssPPARb1A predominating in liver and ssPPARb2A predominating in gill. Expression levels of mRNA of either isotypes were up to tenfold lower in kidney, heart, spleen, muscle, and brain. In cellular transfection assays, ssPPARb1A is activated by monounsaturated fatty acids, 2-bromopalmitate, and mammalian PPARb-specific ligand GW501516. In contrast, PPARb2A was not activated by any of the compounds tested. Furthermore, ssPPARb2A repressed both the basal reporter gene activity and the GW501516-induced activity of ssPPARb1A. The results indicate unexpected levels of variety and complexity in PPAR subtype and mechanism of action in lower vertebrates.
Introduction
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. Originally isolated from humans, rodents, and amphibians, they are now widely accepted to be critical regulators of lipid and energy homeostasis (Isseman & Green 1990 , Krey et al. 1993 , Desvergne & Wahli 1999 , Hihi et al. 2002 . In mammals, one gene for each of the three PPAR subtypes, PPARa, PPARb (also known as PPARd), and PPARg, is present (Michalik & Wahli 1999) . The role of PPARa is hypothesized to be primarily in controlling the reversible induction of b-oxidation in specific tissues, especially liver, as a response to changing energy requirements and nutritional status. The evidence for this comes most directly from rodents, where PPARa is expressed in cells with high catabolic rates of fatty acid oxidation, such as hepatocytes, cardiomyocytes, kidney proximal tubules, and intestinal mucosa . Indeed, PPARa-null mice are incapable of upregulating fatty acid oxidation during fasting (Kersten et al. 1999 , Leone et al. 1999 . In contrast, mammalian PPARg is considered to play a critical role in fat accumulation, particularly in adipocytes and in lipidaccumulating macrophages (Rosen & Speigelman 2001) . The role of PPARb is less well understood. Various studies suggest that PPARb has a role in the global control of lipid homeostasis in mammals. It is moderately activated by a range of unsaturated fatty acids (Forman et al. 1997) and has a broad tissue expression profile . PPARb-null mice show reduced adipose stores (Peters et al. 2000) , which cannot be explained by adipose-specific PPARb deficiency (Barak et al. 2002 , Wang et al. 2003 . Furthermore, in the absence of the ligand, PPARb can act as a repressor of PPARa and PPARg action (Shi et al. 2002) . Similarly, in the cell overexpression systems and in the absence of activating ligand, PPARb can downregulate the genes involved in the lipid and energy metabolism (Tachibana et al. 2005) . Recently, highly specific and potent synthetic ligands for mammalian PPARb have been developed. Treatment of animals with these compounds has demonstrated that ligand-activated PPARb directly controls lipid utilization through upregulation of genes involved in b-oxidation and energy uncoupling in various tissues (Dressel et al. 2003 , Tanaka et al. 2003 , Wang et al. 2003 , Tachibana et al. 2005 . In consequence, PPARb ligands can have beneficial effects in correcting dyslipodemic states in various animal disease models. Thus, PPARb ligands are now receiving considerable attention as potential pharmaceuticals for the treatment of a variety of human diseases associated with dyslipidemia (Desvergne et al. 2004) .
In addition to functioning as a regulator of energy metabolism, PPARb has also been shown to have significant roles in the control of cellular proliferation and differentiation. Studies on PPARb-null mice have indicated the PPARb functions in skin wound healing , keratinocyte differentiation (Schmuth et al. 2002 , Kim et al. 2006 in apoptosis (Di-Poi et al. 2002) , and skin and colon carcinogenesis , Kim et al. 2004 .
Despite these developments, bona fide endogenous ligands for PPARb have still not been conclusively defined and the precise role of PPARb in lipid and energy metabolism, and how this relates to PPARb function in cellular differentiation and proliferation, is not yet understood. The study of PPARs in lower vertebrates such as fish offers an opportunity to compare expression, define common ligands, and infer common functions across vertebrates, thus informing studies on PPARs in humans. Recently, a study on two members of a major fish clade, the Perciformes, reported the identification and characterization of homologs of PPARa, b, and g (Leaver et al. 2005) . Comparison of these gene sequences with information from the pufferfish (Takifugu rubripides and Tetraodon nigroviridis, also Perciformes) genome-sequencing projects suggested that these fishes possessed a single PPARb gene and that they shared many of the features of their mammalian counterpart. However, examination of the zebrafish genome database indicated that there are two PPARb genes in this Cypriniform species. Consequently, the exact number of genes and/or the presence of distinct PPAR isoforms in fish are yet to be determined. Here, we show that multiple PPARb genes are present in Atlantic salmon, a commercially important member of a third major fish clade, the Salmoniformes. Two of these gene products are demonstrated to differ in tissue expression profile and transactivation properties.
Materials and methods

Isolation of Atlantic salmon PPAR genes
An Atlantic salmon genomic DNA library was constructed in lFIXII (Stratagene, La Jolla, CA, USA) from DNA isolated from blood from a single individual. This library was screened with a 32 P-labeled DNA probe corresponding to the ligand-binding domain (LBD) of plaice (Pleuronectes platessa) PPARb (Leaver et al. 2005) . Hybridizing clones were isolated, phage DNA purified, restriction digested, and subjected to Southern blot analysis using the plaice PPARb probe. Hybridizing restriction fragments were then subcloned to plasmid vectors and sequenced using an ABI 477 autosequencer and BigDye sequencing reagents. Sequences were analyzed using Autoassembler software supplied by Applied Biosystems.
Isolation of Atlantic salmon PPARb cDNAs
Full-length cDNAs were isolated from total salmon liver RNA using reverse transcription, PCR, and RACE (SMART RACE system, BD Clontech, Oxford, UK). Gene-specific primers (P1, P2, and P3; Fig. 1 and Table 1 ) were directed to the regions immediately adjacent to PPARb termination codons predicted from genomic sequencing. These primers were combined in 5 0 -RACE PCRs with SMART liver cDNA and the SMART system universal primer. Further, RACE PCR was performed with primers synthesized to specific regions within the products arising from the first round of reactions. These primers (P4 and P5; Fig. 1 and Table 1) were used in nested PCR procedures. Finally, full-length open reading frames for salmon PPARb cDNAs were obtained using both forward and reverse gene-specific primers (P1, P6, P7, and P8; Fig. 1 and Table 1) , designed from consideration of the previously isolated RACE products. All products were ligated to Escherichia coli plasmid vectors and sequenced.
Tissue expression
Total RNA was isolated from tissues of three Atlantic salmon (average massZ200 g) using TriReagent (Sigma). For quantitative PCR (QPCR), 1 mg total RNA was converted to cDNA using a blend of poly-dT oligonucleotide primer (25 nM) and random hexamers (75 nM), and Reverse-iT reverse transcriptase (AMV/ MMuLV blend; Abgene, Epsom, Surrey, UK). QPCRs of 20 ml contained 100 nM of each primer, cDNA from the equivalent of 25 ng total RNA for PPARb reactions and from the equivalent of 0 . 25 ng RNA for 18S rRNA reactions. Amplicons were quantified using SYBR Green PCR mastermix (Abgene) and a Techne Quantica QPCR instrument. Cycling parameters consisted of a 15-min 95 8C soak to activate the polymerase, followed by 40 cycles of 95 8C for 15 s and 60 8C for 1 min. Primers were directed to areas where the two cDNAs exhibited low nucleotide identity, either side of the junction corresponding to the first exon of the LBD of each PPAR. For ssPPARb1A, these were 5 0 -GACCACCAACCC-CAATGGCTCGGAT and 5 0 -CAGCCCATTCTCAGCCT-GGCACAAG, and for ssPPARb2A, 5 0 -CCCCCACCATCT TGGTGGCTCAGA and 5 0 -TAGACCACTCTCTGCTTG-CCACAGG. The PCR products produced from these primers under QPCR conditions were checked by gel electrophoresis and sequencing before undertaking QPCR. In each case, only the predicted products of 176 and 190 bp for ssPPARb1A and ssPPARb2A respectively, were amplified. Values for PPARb were normalized to 18S rRNA levels measured with primers 5 0 -CTGCCCTATCAACTTTCGATGGTACT and 5 0 -AA-AGTGTACTCATTCCAATTACGGGG.
Cell transfection experiments
Salmon PPARb cDNAs were ligated to pcDNA3 and used to transfect AS (derived from Atlantic salmon, epitheloid; Nicholson & Byrne 1973) cells with pCMVbgal and a reporter construct containing a PPRE from the mouse cyp4A6 promoter (Ijpenberg et al. 1997) linked to a chloramphenicol acetyltransferase (CAT) gene. AS cells were routinely grown and passaged in Dulbecco's modified Eagle's medium (DMEM), 10% fetal bovine serum (FBS). Prior to transfection, cells were passaged into DMEM, plus charcoal/dextran-stripped 10% FBS (Pierce, Rockford, IL, USA). Total plasmid DNA (1 . 5 mg) was transfected to each well of 12-well tissue culture plates using 7 . 5 ml Superfect reagent according to the manufacturer's instructions (Qiagen). Twentyfour hours after transfection, cells were treated with fatty acids (100 mM; Sigma), Wy16463 (50 mM), rosiglitazone, GW501516 (10 mM; Alexis Corporation, Nottingham, UK), and L165041 (10 mM; Calbiochem, Nottingham, UK) in 5 ml ethanol. Cells were harvested 24 h after treatment, lysed in 300 ml detergent-based buffer, and CAT protein was measured using an ELISA method (Roche). b-Galactosidase activity was measured in a microtitre plate-based assay. Briefly, 20 ml cell lysate was incubated with 130 ml PBS containing 5 mM MgCl 2 , 10 mM b-mercaptoethanol, and 1 . 5 mM O-nitrophenylb-galactoside (ONPG). After 30 min, the reaction was stopped by the addition of 75 ml of 1 M Na 2 CO 3 and the A 420 measured. CAT quantity was normalized to b-galactosidase activity and, after subtracting mocktransfected blank values, values for each treatment were expressed relative to the ethanol control for pcDNA3 (empty vector). All treatments were performed in triplicate.
Results
Atlantic salmon possesses four distinct PPARb genes
The salmon genomic library was screened with a probe corresponding to the LBD of a plaice PPARb (Leaver et al. 2005) , and a total of nine distinct phage inserts were found to contain PPARb-related sequences. Assembly of the sequences from these nine inserts produced four distinct clone sets, each comprised overlapping genomic fragments. Comparisons of exon sequences corresponding to the LBD of PPARb suggested that they contained distinct sequences. Based on the genomic sequence information, oligonucleotide primers were designed to be specific for each PPARb sequence. Initially, primers were directed to the regions adjacent to the termination codons of each of the three gene sequences (L1, L29, and L92 clone sets; Fig. 1 ). For the L1 clone set, a single cDNA was isolated (designated as ssPPARb1A), which was found to contain a full-length open reading frame for PPARb. For L92, a partial cDNA was obtained, containing only the coding region corresponding to the LBD of PPARb. This cDNA was distinct from ssPPARb1A. No PPARb cDNAs were obtained for the L29 clone set (designated as ssPPARb1B). Using the partial cDNA sequence derived from the L92 clone set, two more oligonucleotides were designed to areas within the region corresponding to the LBD. These were used in a nested 5 0 -RACE procedure and two distinct cDNAs were obtained. One of these cDNAs contained an open reading frame for a PPARb isoform distinct from both ssPPARb1A and the partial L92 cDNA, and was P1  TAAACCAGTCCAGTCAGTACATGTCC  P2  CAGTCAGTACATGTCCTTATAGATC  P3  TTCCAGTCAGTACAGATTTAGTCCGGT  P4  CTTGGGGAAGACATAGAGGGAGTCCTG  P5  TCGTTAAGGAAGAGATCCACAAACCCT  P6  CAGGATCCATGGGTAGCCAACAGAATGGAGAGATTG  P7  AAGGTACCAGTCAGTACATGTCCTTATAGATCTCCT  P8 CTTGGATCCTGGGACATGAAG Atlantic salmon PPARb . M J LEAVER and others 393 designated ssPPARb2A (corresponding to the L6 clone set). The other cDNA corresponded, with 100% nucleotide identity in the overlapping region, to the previously isolated partial L92 cDNA. This cDNA contained an open reading frame, which lacked a DNA-binding domain but possessed an intact A/B domain and LBD, and together with the gene in the L92 clone set was designated ssPPARb2B. The gene and cDNA sequences corresponding to the exons encoding the LBD of each of the presumed PPARb genes were aligned, together with exon-flanking regions (Fig. 2) . The percentage identity matrices for these alignments showed that one of the cDNA sequences (ssPPARb1A) was identical to the gene present in the L1 clone set. The other full-length cDNA (ssPPARb2A) showed between 98 and 100% identity to clone set L6, whilst the atypical ssPPARb2B cDNA showed between 99 and 100% identity to the L92 clone set. Further attempts were made to isolate a cDNA (ssPPARb1B) corresponding to the L29 genomic sequence from gill, kidney, and muscle cDNA, but were unsuccessful. It should be noted that the materials for the construction of genomic and cDNA libraries were derived from different individuals; thus, the small differences observed between these cDNAs and genes are most likely the result of allelic variation within salmon populations. In addition, apparent from the identity matrices, the clone sets fall into two groups of two genes each, with about 80% identity between the members from different groups. Exon-flanking sequences from the genes were compared to determine whether the four genes were from distinct loci, or were allelic variants from two loci. From Fig. 2 , it is apparent that, although there is some similarity in the exon-flanking regions between L29 and L1, and between L6 and L92 clone sets, there is a lower level of identity than might be expected of allelic variants. This indicates that there are at least four distinct PPARb genes in salmon.
Atlantic salmon PPARb phylogeny
Comparison of the deduced amino acid sequences of the full-length ssPPARb1A and ssPPARb2A cDNAs clearly demonstrated that both salmon PPARs phylogenetically clustered with PPARb subtypes from diverse vertebrates (Fig. 3) . The salmon PPARs were most closely related to PPARs from other fish species. However, it is notable that, within the PPARb phylogeny, the two zebrafish PPARb isoforms do not resolve on the same branches as the salmon isoforms, and in any case their positions in the phylogeny are not well supported by bootstrap values. Most amino acid identity between the salmon isoforms and PPARb from other vertebrates was evident in the DNA-and ligand-binding regions, although there were also areas of cross-species identity in both the AB-and D-domains (Fig. 4) . In both ssPPARb1A and ssPPARb2A, the amino acid residues that interact with fatty acid ligand and co-activator proteins are conserved (Nolte et al. 1998 , Xu et al. 1999 , Fyffe et al. 2006 ).
Differential tissue expression of salmon PPARb genes
QPCR analysis of salmon PPARb expression across a range of tissues indicated that there were differences in relative expression levels (Fig. 5) . ssPPARb1A was most highly expressed in liver and adipose, whilst ssPPARb2A was most highly expressed in gill and adipose. The levels of ssPPARb1A exceeded those of ssPPARb2A in liver. In gill, ssPPARb2A was the predominant isoform and both were expressed equally in adipose. The expression levels in other tissues were three-to fivefold lower than in liver, gill, and adipose, and there were no differences between the expression level of ssPPARb1A and ssPPARb2A.
Differential transactivation of salmon PPARb subtypes
In cellular transfection assays (Fig. 6) , there was a relatively small but significant activation of ssPPARb1A by palmitoleic acid. In contrast, there was no apparent effect of oleic, linolenic, arachidonic, eicosapentenoic, or docosahexaenoic acids. There was a much greater response to the mammalian PPARb-specific ligand GW501516 and bromopalmitate. However, L165041, another mammalian PPARb-selective ligand, was not an effective activator of salmon ssPPARb1A. Note that all compounds that resulted in the activation of ssPPARb1A also induced the basal activity of the reporter construct, suggesting the presence of endogenous ssPPARb1A. Indeed, QPCR indicated that ssPPARb1A was present (not shown) in the AS cell line although at lower levels per unit input RNA than any of the salmon tissues tested. This may indicate that fatty acids are effective activators of ssPPARb1A, since they all induced reporter gene activity significantly above that induced by the vehicle ethanol. Transfection of the ssPPARb2A significantly reduced the basal level of transcription from the reporter construct with all tested compounds (Fig. 6 ), suggesting repression of endogenous ssPPARb1A activity in the AS cell line. To test this, AS cells were transfected with both ssPPARbA1 and ssPPARb2A, and reporter gene activation measured after GW501516 treatment. The results confirmed (Fig. 7 ) that ssPPARb2A repressed both the basal and the GW501516-induced activity of ssPPARb1A, as well as the endogenous basal and induced activity.
Discussion
Atlantic salmon are both a declining wild species with a complex and characteristic life cycle and a commercially valuable farmed species. The management of both wild and farmed stocks is as rich in social, economic, and political issues as its resource base is rich biologically. However, a particular biological problem which concerns both the survival of wild fish and the quality of farmed fish is related to the control of energy and, particularly, lipid homeostasis. PPARs are now known to be critical regulators of these processes. The study presented here is the first report of the functional characterization of PPAR subtypes from a salmonid species, the Atlantic salmon. Phylogenetic analysis shows that all the four genes described here belong to the PPARb subfamily. In mammals, where PPARs have been studied most intensively, a single gene encodes for PPARb, and studies in other fish species have identified varying numbers of PPARb subtypes. BLAST searches of near complete genome sequences for the pufferfishes, Takifugu rubripes and Tetraodon nigroviridis, reveal the presence of only one PPARb gene. Similarly, in plaice and sea bream, it has previously been reported that only one PPARb gene is detectable (Leaver et al. 2005) . This compares with the situation in zebrafish, where, from genomic sequence and published information, there is clear evidence of two PPARb isoforms (Robinson-Rechavi et al. 2001 , Leaver et al. 2005 . Of the four Atlantic salmon sequences identified here, at least two appear to be functional genes for PPARb (termed here ssPPARb1A and ssPPARb2A), as shown by the identification of corresponding cDNAs containing complete coding sequence. It is not clear whether our failure to isolate fully resolved cDNAs for the other two gene sequences is because these are not functional genes or because they are not expressed. It is nevertheless important to note that for one of the other genes (ssPPARb2B), we were able to isolate a cDNA with an open reading frame containing an AB-domain, a D-domain, and a ligandbinding domain, but lacking a DNA-binding domain. It
is not yet clear whether this represents an aberrantly or partially processed mRNA or codes for an atypical but functional PPARb subtype. For the other gene (ssPPARb1B), through sequence homology, we could identify six out of seven coding exons on a single lambda genomic clone (not shown; Accession numbers AM229298 and AM229299). The first coding exon of ssPPARb1B could not be definitively established because of the uncertainty in predicting this less conserved region of the gene by homology. Nevertheless, it is likely that this gene also encodes a functional PPAR. Attempts to isolate a cDNA for this gene from a variety of tissues were not successful, suggesting that it is either not expressed or is expressed in a tissue or developmentally restricted manner. The presence of four PPARb genes in salmonids is most probably a result of a relatively recent polyploidization event (60-90 million years), which is clearly evident in the evolution of salmonids (Allendorf & Thorgaard 1984) . Moreover, more ancient polyploidization events have been proposed as a driving force for the evolution of the vertebrate lineage (Ohno 1970) . One of these has been proposed to have occurred in the early evolution of ray-finned fishes (Taylor et al. 2003) and recent comparative syntenic analyses of zebrafish and pufferfish genomes (Woods et al. 2005) have supported this event and inferred subsequent lineagespecific duplications or losses to account for the differences in gene numbers between these species. The four PPARb genes in Atlantic salmon clearly group into two subfamilies most likely representing the polyploidization-dependent duplication of two PPARb subtypes from an ancestral diploid salmonid, these two genes arising from the more ancient ray-finned fish event. The phylogenetic analysis suggests that these two salmon subfamilies are not orthologous to the two PPARb subtypes in zebrafish, although it should be noted that the zebrafish sequences are not placed in the tree with high confidence and a definitive conclusion must await functional characterization of the zebrafish PPARb subtypes.
From an evolutionary perspective, a key question surrounding the process of polyploidizaton is how an individual with a polyploid genome would gain a selective advantage in a population and thence give rise to a new polyploid species. For such polyploidized individuals to reproduce successfully, they are required to undergo a process of diploidization concurrent with functional divergence of duplicated loci to obtain a selective advantage over their diploid relatives (Wolfe 2001) . The genetic divergence of PPARb subtypes in salmon may be an example of the outcome of this diploidization process, and as such these genes would be expected to exhibit functional divergence. Indeed, our results indicate that ssPPARb1A or ssPPARb2A are differentially expressed and exhibit distinct activation characteristics. Levels of ssPPARb1A predominate in liver and ssPPARb2A predominate in gill and the differential expression of salmon PPARb isoforms has functional significance when the cellular transfection results are considered. It would appear that ssPPARb1A is similar in ligand-activation profile to PPARb from other species (Forman et al. 1997 , Oliver et al. 2001 , Leaver et al. 2005 ) being responsive to palmitoleic and oleic acids and to 2-bromopalmitate. Importantly, it is highly activated by the mammalian PPARb-selective ligand GW501516, but not activated by the PPARaspecific ligand WY146463. The response to GW501516 suggests that, as with PPARb in mammals, this compound is a ligand for ssPPARb1A. The identification of highly selective and potent ligands for fish PPARs is a necessary step in advancing understanding in this area and further studies are required to test whether GW501516 will be as selective and potent in salmon as it is in mammals. On the other hand, the lack of response of ssPPARb2A to fatty acids or PPARbselective ligands is intriguing. Consideration of the LBD of ssPPARb2A suggests that this may be because there are critical differences between the sequence of this isoform and the sequences of mammalian or other characterized fish PPARb homologs. A number of amino acid residues are not conserved in the ssPPARb2A subtype (Fig. 4) , which may change the characteristics of the LBD. However, none of these substitutions are at positions shown to be involved in either fatty acid ligand binding (Xu et al. 1999 , Fyffe et al. 2006 or co-activator binding to human PPAR (Nolte et al. 1998) , suggesting that ssPPARb2A may be capable of binding and being activated by as yet undiscovered ligands. It is possible that, if the two salmon subtypes have conserved functions and binding specificity, the true endogenous ligand for vertebrate PPARb may not be fatty acids, but might in future be identified as a compound which activates both ssPPARb1A and ssPPARb2A. Alternatively, the nonconserved substitutions or other characteristics of ssPPARb2A may prohibit ligand activation under any circumstances and its sole function may be to repress the activity of other PPARs. Mammalian PPARb has been shown to repress the activity of the other PPAR subtypes by competing for binding to PPREs (Shi et al. 2002) . In this respect, the repressive ability of ssPPARb2A in both basal and GW501516-induced transcriptional activity is significant. The high levels of expression of ssPPARb2A in gill, in combination with its repressive activity, may have specific implications for the action of other PPAR subtypes in this tissue. As the fish gill is in close contact with the external environment, a single layer of epithelial cells separating the blood from the water, it is possible that in this tissue ssPPARb2A functions to repress the activity of other PPARs in order to prevent their un-programmed activation by exogenous compounds or contaminants. Thus, Atlantic salmon may have evolved novel PPARb-dependent processes. In this regard, it is important to note that other salmonids, such as rainbow trout and brown trout (Onchorhyncus mykiss and Salmo trutta), are also polyploid and would thus contain homologs of the four salmon PPARb genes. Previous studies (Batisto-Pinto et al. 2005 , Lui et al. 2005 ) of tissue expression profiles and PPAR-agonist responses in these species have considered only a single PPARb subtype identified from partial cDNA sequences. In future, and in the light of these results from salmon, such studies should be conducted with the expectation of the presence of multiple PPAR subtypes with divergent function in trout and other salmonids.
In conclusion, these studies demonstrate the possibility for unexpected levels of variety in PPARb subtype and mechanism of action in Atlantic salmon, showing that further complexity in physiological control may result from functional divergence of duplicated nuclear receptor genes. Further studies are required to understand the role of these important regulators of lipid homeostasis in life cycle and evolutionary adaptation in salmonids and to determine common PPAR-dependent processes across all vertebrates.
